Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplication

Department of Internal Medicine V, Heidelberg University Hospital
Institute of Medical Biometry, University of Heidelberg
Clinical Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center
Clinical Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center
Institute of Medical Biometry, University of Heidelberg
Department of Medicine I – Hematology and Cell Therapy, Leipzig University Hospital
Department of Medicine A, Münster University Hospital
Department of Hematology, Oncology and Palliative Medicine, Robert-Bosch Hospital Stuttgart
Institute of Medical Biometry, University of Heidelberg
Department of Medicine I – Hematology and Cell Therapy, Leipzig University Hospital
Department of Internal Medicine V, Heidelberg University Hospital
Department of Internal Medicine V, Heidelberg University Hospital, Germany; Clinical Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center
Haematologica Early view Nov 20, 2025 https://doi.org/10.3324/haematol.2025.288362

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2025.288362
 
Published
2025-11-20
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
268
PDF Downloads
167

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online